Facebook Twitter YouTube Google Plus

Mesothelioma Resources | Mesothelioma Podcast Series

Meet the Mesothelioma Experts

As part of the Meet the Mesothelioma Experts series, the Meso Foundation invites specialists in the field of mesothelioma to discuss their current research interests as well as promising developments in the treatment of mesothelioma. Below, you can view and register for the upcoming session and you can also listen to audio files of past sessions. If you wish to receive emails from the Meso Foundation, including alerts about new installments of the Meet the Mesothelioma Experts series, please click here.

Upcoming Session:

Check back soon for our next installment of Meet the Mesothelioma Experts series.

Past Session Podcasts:

An Interview with William A. Franco and Julie P. Pawelczyk of The Conafay Group
During the teleconference, Mr. Franco and Ms. Pawelczyk provide an inside look into Capitol Hill and discuss best practices for making a difference through advocacy.

Drs. Natalie Sacks & Evan AlleyAn Interview with Aduro Biotech
Our guests on behalf of Aduro Biotech, Drs. Natalie Sacks and Evan Alley, discuss Aduro Biotech's mesothelioma clinical trial.

Daniel H. Sterman, MD

Targeting the Immune System with Daniel H. Sterman, MD
Dr. Sterman of the New York University Langone Medical Center discusses his work in the field of mesothelioma treatment and research as it pertains to targeting the immune system.

Marjorie Zauderer, MD

Meet Marjorie Zauderer, MD, of Memorial Sloan Kettering Cancer Center
Dr. Marjorie Zauderer discusses her work in the field of mesothelioma as a medical oncologist at Memorial Sloan Kettering Cancer Center.

Dr. Raphael Bueno

Current Trends in Mesothelioma Surgery and Research: The International Mesothelioma Program at Brigham and Women's Hospital
Dr. Raphael Bueno discusses his work as the chief of thoracic surgery at Brigham and Women's Hospital and the future of his mesothelioma program.

2015 Grant Recipient Interviews
We interview grant recipients Dr. Andrea McClatchey of the Massachusetts General Hospital in Boston, Dr. Sean Carlin of Memorial Sloan Kettering Cancer Center in New York, and Dr. Jill Ohar of Wake Forest University in Winson-Salem, NC.

Focus on Centers of Excellence: Penn Medicine with Dr. Evan Alley and Dr. Charles Simone
Overview of the Penn Mesothelioma and Pleural Program.

Focus on Mesothelioma Centers of Excellence: Hedy Lee Kindler, MD, University of Chicago Medicine
Dr. Hedy Lee Kindler, an internationally recognized cancer expert, discusses her work as the Director of Mesothelioma and Gastrointestinal Programs at the University of Chicago Medicine.

CRS-207: Using a Modified Listeria Virus to Fight Mesothelioma
Stephen Isaacs of Aduro Biotech discusses the company's experimental therapy for malignant pleural mesothelioma, known as CRS-207, a weakened form of the listeria bacteria.

Mesothelioma Clinical Trial Using PD-L1 Inhibitors
Dr. Evan Alley of the University of Pennsylvania discusses his new clinical trial for pleural mesothelioma patients, which is looking into an agent that would inhibit the PD-L1 protein.

Defactinib, a New Investigational Agent for Mesothelioma
Dr. Joanna C. Horobin of Verastem, Inc. discusses the company’s latest investigational agent, defactinib, which is being developed for use in patients with pleural mesothelioma.

Focused Discussion of a New Clinical Trial: GL-ONC1
Dr. Valerie Rusch of the Memorial Sloan Kettering Cancer Center discusses her new clinical trial for mesothelioma patients, GL-ONC1.

New Frontiers in Surgery for Mesothelioma
Dr. Joseph Friedberg of the University of Pennsylvania discusses mesothelioma surgery with an emphasis on photodynamic therapy, a type of treatment that uses light therapy to destroy cancer cells.

Designing Clinical Trials for Mesothelioma
Melissa Culligan, RN, BSN, MS, of the University of Pennsylvania discusses what goes into designing mesothelioma clinical trials.

Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma
Dr. Tobias Peikert of the Mayo Clinic discusses his clinical trial, which uses the measles virus to attack mesothelioma cells in pleural mesothelioma patients.

NGR-hTTNF: A New Multi-Center Drug Trial for Pleural Mesothelioma
Dr. Julie Brahmer of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital discusses her clinical trial, which uses a new chemotherapy treatment designed specifically for pleural mesothelioma patients.

Mesothelin: A New Target for Immunotherapy
Dr. Raffit Hassan of the National Cancer Institute discusses his research into mesothelin and development of clinical trials using mesothelin as a target for epithelial malignant mesothelioma, providing both pleural and peritoneal mesothelioma patients with the potential of much-needed new treatment options.

Recent Advances in Mesothelioma Gene Therapy
Dr. Daniel Sterman of the University of Pennsylvania discusses recent advances in the field of mesothelioma gene therapy.

Vaccines: can we manipulate the immune system to prevent recurrence following a PD/EPP?
Dr. Lee Krug of the Memorial Sloan Kettering Cancer Center discusses a clinical trial that answers the title questions.

**Any call conferencing and/or unauthorized transmission, broadcast, retransmission, rebroadcast, or republishing of the podcasts without the express written consent of the Mesothelioma Applied Research Foundation is strictly prohibited and may be illegal.